Lista de obras - Luca Longo - Dominio Público Uruguay

A genome-wide microRNA profiling indicates miR-424-5p and miR-503-5p as regulators of ALK expression in neuroblastoma.

artículo científico publicado en 2017

A high-content screening of anti-cancer compounds suggests the multiple tyrosine kinase inhibitor ponatinib for repurposing in neuroblastoma therapy.

artículo científico publicado en 2018

An 18 gene expression-based score classifier predicts the clinical outcome in stage 4 neuroblastoma.

artículo científico publicado en 2016

Autophagy inhibition improves the cytotoxic effects of receptor tyrosine kinase inhibitors.

artículo científico publicado en 2018

Co-Administration of Fendiline Hydrochloride Enhances Chemotherapeutic Efficacy of Cisplatin in Neuroblastoma Treatment

artículo científico publicado en 2020

Combined therapeutic effects of vinblastine and rapamycin on human neuroblastoma growth, apoptosis, and angiogenesis

artículo científico publicado en 2007

Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression

artículo científico publicado en 2016

Familial neuroblastoma: a complex heritable disease.

artículo científico publicado en 2003

Genetic Predisposition to Familial Neuroblastoma: Identification of Two Novel Genomic Regions at 2p and 12p

artículo científico publicado en 2007

Genetic abnormalities in adolescents and young adults with neuroblastoma: A report from the Italian Neuroblastoma group

artículo científico publicado en 2015

Genome analysis and gene expression profiling of neuroblastoma and ganglioneuroblastoma reveal differences between neuroblastic and Schwannian stromal cells

artículo científico publicado en 2005

Genome-Wide Linkage Analysis to Identify Genetic Modifiers of <i>ALK</i> Mutation Penetrance in Familial Neuroblastoma ⬇️

artículo científico publicado el 6 de julio de 2011

High-resolution array CGH profiling identifies Na/K transporting ATPase interacting 2 (NKAIN2) as a predisposing candidate gene in neuroblastoma

artículo científico publicado en 2013

Identification of ALK as a major familial neuroblastoma predisposition gene

artículo científico publicado en 2008

Identification of ALK germline mutation (3605delG) in pediatric anaplastic medulloblastoma.

artículo científico publicado en 2012

Identification of GALNT14 as a novel neuroblastoma predisposition gene

artículo científico publicado en 2015

Impact of interleukin-6 -174 G>C gene promoter polymorphism on neuroblastoma

artículo científico publicado en 2013

Inhibition of N-linked glycosylation impairs ALK phosphorylation and disrupts pro-survival signaling in neuroblastoma cell lines ⬇️

artículo científico publicado el 22 de diciembre de 2011

Mutation-independent anaplastic lymphoma kinase overexpression in poor prognosis neuroblastoma patients

artículo científico publicado en 2009

NAC, tiron and trolox impair survival of cell cultures containing glioblastoma tumorigenic initiating cells by inhibition of cell cycle progression.

artículo científico publicado en 2014

Oligogenic inheritance in neuroblastoma

artículo científico publicado en 2005

PHOX2B mutations and genetic predisposition to neuroblastoma

Perhexiline maleate enhances antitumor efficacy of cisplatin in neuroblastoma by inducing over-expression of NDM29 ncRNA.

artículo científico publicado en 2015

Precision Medicine for NSCLC in the Era of Immunotherapy: New Biomarkers to Select the Most Suitable Treatment or the Most Suitable Patient

scientific article published on 30 April 2020

Proteomic analysis uncovers common effects of IFN-γ and IL-27 on the HLA class I antigen presentation machinery in human cancer cells.

artículo científico publicado en 2016

Radiomic detection of EGFR mutations in NSCLC

scientific article published on 04 November 2020

Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibility

artículo científico publicado en 2012

Role of CXCL13-CXCR5 crosstalk between malignant neuroblastoma cells and Schwannian stromal cells in neuroblastic tumors.

artículo científico publicado en 2011

Two regions of deletion in 9p22- p24 in neuroblastoma are frequently observed in favorable tumors

scientific article published on 01 May 2002

Weak linkage at 4p16 to predisposition for human neuroblastoma

artículo científico publicado en 2002

Lista de obras de Luca Longo

A genome-wide microRNA profiling indicates miR-424-5p and miR-503-5p as regulators of ALK expression in neuroblastoma.

A high-content screening of anti-cancer compounds suggests the multiple tyrosine kinase inhibitor ponatinib for repurposing in neuroblastoma therapy.

An 18 gene expression-based score classifier predicts the clinical outcome in stage 4 neuroblastoma.

Autophagy inhibition improves the cytotoxic effects of receptor tyrosine kinase inhibitors.

Co-Administration of Fendiline Hydrochloride Enhances Chemotherapeutic Efficacy of Cisplatin in Neuroblastoma Treatment

Combined therapeutic effects of vinblastine and rapamycin on human neuroblastoma growth, apoptosis, and angiogenesis

Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression

Familial neuroblastoma: a complex heritable disease.

Genetic Predisposition to Familial Neuroblastoma: Identification of Two Novel Genomic Regions at 2p and 12p

Genetic abnormalities in adolescents and young adults with neuroblastoma: A report from the Italian Neuroblastoma group

Genome analysis and gene expression profiling of neuroblastoma and ganglioneuroblastoma reveal differences between neuroblastic and Schwannian stromal cells

Genome-Wide Linkage Analysis to Identify Genetic Modifiers of &lt;i&gt;ALK&lt;/i&gt; Mutation Penetrance in Familial Neuroblastoma ⬇️

High-resolution array CGH profiling identifies Na/K transporting ATPase interacting 2 (NKAIN2) as a predisposing candidate gene in neuroblastoma

Identification of ALK as a major familial neuroblastoma predisposition gene

Identification of ALK germline mutation (3605delG) in pediatric anaplastic medulloblastoma.

Identification of GALNT14 as a novel neuroblastoma predisposition gene

Impact of interleukin-6 -174 G>C gene promoter polymorphism on neuroblastoma

Inhibition of N-linked glycosylation impairs ALK phosphorylation and disrupts pro-survival signaling in neuroblastoma cell lines ⬇️

Mutation-independent anaplastic lymphoma kinase overexpression in poor prognosis neuroblastoma patients

NAC, tiron and trolox impair survival of cell cultures containing glioblastoma tumorigenic initiating cells by inhibition of cell cycle progression.

Oligogenic inheritance in neuroblastoma

PHOX2B mutations and genetic predisposition to neuroblastoma

Perhexiline maleate enhances antitumor efficacy of cisplatin in neuroblastoma by inducing over-expression of NDM29 ncRNA.

Precision Medicine for NSCLC in the Era of Immunotherapy: New Biomarkers to Select the Most Suitable Treatment or the Most Suitable Patient

Proteomic analysis uncovers common effects of IFN-γ and IL-27 on the HLA class I antigen presentation machinery in human cancer cells.

Radiomic detection of EGFR mutations in NSCLC

Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibility

Role of CXCL13-CXCR5 crosstalk between malignant neuroblastoma cells and Schwannian stromal cells in neuroblastic tumors.

Two regions of deletion in 9p22- p24 in neuroblastoma are frequently observed in favorable tumors

Weak linkage at 4p16 to predisposition for human neuroblastoma

Genome-Wide Linkage Analysis to Identify Genetic Modifiers of <i>ALK</i> Mutation Penetrance in Familial Neuroblastoma ⬇️